SIM
ALDX icon

Spark Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

Spark Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,300
Closed -$40K – 90
2020
Q1 		$40K Buy
+16,300
New +$73.3K 0.02% 323
2015
Q4 		– Sell
-18,400
Closed -$105K – 745
2015
Q3 		$105K Sell
18,400
-3,600
-16% -$28.1K 0.01% 597
2015
Q2 		$170K Sell
22,000
-700
-3% -$6.04K 0.02% 546
2015
Q1 		$230K Buy
22,700
+11,500
+103% +$117K 0.03% 525
2014
Q4 		$77K Buy
+11,200
New +$80.3K 0.01% 604

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Spark Investment Management's ALDX Position: Q2 2020 in Review

Spark Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q2 2020, closing a stake of 16,300 shares — an estimated $40K sold.

Spark Investment Management first reported a position in ALDX in Q4 2014 and held it in 5 quarters. The position peaked at $230K in Q1 2015. 84 funds tracked by Wall St. Rank hold ALDX as of Q2 2020.

  • Spark Investment Management reported no remaining Aldeyra Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 16,300 Aldeyra Therapeutics shares in Q2 2020, an estimated $40K.
  • Spark Investment Management first reported a position in Aldeyra Therapeutics in Q4 2014 and held it in 5 quarters.
  • Spark Investment Management's Aldeyra Therapeutics position peaked at $230K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.